Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL, USA.
Am J Transplant. 2011 Mar;11(3):450-62. doi: 10.1111/j.1600-6143.2010.03283.x. Epub 2010 Oct 25.
Renal allograft survival has increased tremendously over past decades; this has been mostly attributed to improvements in first-year survival. This report describes the evolution of renal allograft survival in the United States where a total of 252 910 patients received a single-organ kidney transplant between 1989 and 2009. Half-lives were obtained from the Kaplan-Meier and Cox models. Graft half-life for deceased-donor transplants was 6.6 years in 1989, increased to 8 years in 1995, then after the year 2000 further increased to 8.8 years by 2005. More significant improvements were made in higher risk transplants like ECD recipients where the half-lives increased from 3 years in 1989 to 6.4 years in 2005. In low-risk populations like living-donor-recipients half-life did not change with 11.4 years in 1989 and 11.9 years in 2005. First-year attrition rates show dramatic improvements across all subgroups; however, attrition rates beyond the first year show only small improvements and are somewhat more evident in black recipients. The significant progress that has occurred over the last two decades in renal transplantation is mostly driven by improvements in short-term graft survival but long-term attrition is slowly improving and could lead to bigger advances in the future.
在过去的几十年中,肾移植的存活率有了显著提高;这主要归因于第一年存活率的提高。本报告描述了美国肾移植存活率的演变,在 1989 年至 2009 年间,共有 252910 名患者接受了单器官肾移植。半衰期通过 Kaplan-Meier 和 Cox 模型获得。1989 年,死亡供体移植的移植物半衰期为 6.6 年,1995 年增加到 8 年,2000 年后进一步增加到 2005 年的 8.8 年。在 ECD 受体等高危移植中取得了更显著的进展,半衰期从 1989 年的 3 年增加到 2005 年的 6.4 年。在低危人群中,如活体供体受体,半衰期在 1989 年没有变化,为 11.4 年,在 2005 年为 11.9 年。所有亚组的第一年损耗率都有显著改善;然而,第二年以后的损耗率仅略有改善,在黑人受者中更为明显。过去二十年肾移植取得的重大进展主要是由于短期移植物存活率的提高,但长期损耗率正在缓慢改善,未来可能会取得更大的进展。